comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 16:28:25 - browse：28

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： ARCH Venture Partners tops STAT's 2023 biotech VC rankings

focus

explore

WSS

AI can’t replace a physician’s gut feeling

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Google and Epic fight stronger regulation of AI in health care

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Cosmetics set for new safety regulation. Why the industry is on board

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

hotspot

comprehensive

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How Robert F. Kennedy Jr. distorted vaccine science

Hepatitis C has a cure — but many Americans still lack access to it

Medicare has a new plan to address drug shortages

Anesthesiologist group: stop taking Ozempic before surgery

Lupron, used to halt puberty in children, may cause lasting health problems

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

At Orexo, a ‘turning point’ for everything but digital health

Hepatitis C has a cure — but many Americans still lack access to it

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

focus

Dexcom's push to bring CGM to type 2 diabetes patients

Biden tests positive for Covid

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Hubble vs. James Webb telescope images: See the difference

STAT Virtual Event: The State of Biosimilars: What to Watch

STAT wants to know your pick for a great summer read or listen

focus

focus

explore

leisure time